NPPES file of Aug 9, 2026

Jacob Chemmalakuzhy, M.D.

Cardiovascular Disease Physician · Irving, TX

Jacob Chemmalakuzhy, M.D. is a cardiovascular disease physician with a practice address in Irving, Texas, and NPI 1992723241, issued on Jul 17, 2006. Check the license (Texas M3986, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1992723241
Name
Jacob Chemmalakuzhy
Credential
M.D.
Primary taxonomy
Cardiovascular Disease Physician 207RC0000X
License numbers
M3986 TX
2002010037 MO
Self-reported in NPPES; status is on the state search
Practice location
6750 N Macarthur Blvd, Irving, TX 75039
Phone
(972) 428-3298
Enumerated
Jul 17, 2006
Record last updated
Mar 1, 2022
Medicaid IDs
181302403 TX
181302402 TX
181302404 TX
Medicare enrollment
Enrolled (PECOS I20060809000162); accepts Medicare assignment
Medical or professional school
University Of Missouri, Kansas City, School Of Medicine, 1998
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 6750 N Macarthur Blvd

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Kristen Carmichael, M.D.Obstetrics & Gynecology Physician1063449411
  2. Kimberly Chesshir, MDObstetrics & Gynecology Physician1972600583
  3. Rupal Chiniwala, M.D.Internal Medicine Physician1013956408
  4. Whitney Chouteau, D.O.Interventional Pain Medicine Physician1639373129
  5. Susan Clifford, M.D.Pediatrics Physician1568402105
  6. Stephanie Copeland, M.D.Pediatrics Physician1740221860

Verify Jacob Chemmalakuzhy in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersTexas Medical Board
    Search for license M3986
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Texas license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

42% fewer Medicare Part D claims than the average cardiovascular disease physician in 2024

1,776 Medicare Part D claims for 282 beneficiaries, against an average of 3,078 among the 20,728 providers of this specialty who prescribed in Part D. Brand-name drugs were 15% of claims.

  1. Jacob Chemmalakuzhy1,776
  2. Specialty average3,078

Most prescribed

  1. Eliquis155 claims
  2. Metoprolol Succinate153 claims
  3. Clopidogrel126 claims
  4. Atorvastatin Calcium118 claims
  5. Losartan Potassium100 claims
  6. Ranolazine Er78 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Industry payments in 2024: $447.05

5 payments; by number, the most common kind was food and beverage; the largest payer was Medtronic, Inc. The 16,686 providers of this specialty with any payment received $3,819.56 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Jacob Chemmalakuzhy$447.05
  2. Specialty average$3,819.56

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Cardiovascular Disease Physician providers in Texas

There are 1,603 cardiovascular disease physician records in Texas.

Other cardiovascular disease physician records in Texas

  1. Ismaile Abdalla, M.D.Amarillo, TX1386610285
  2. Amer Abdulla, MDGalveston, TX1437533205
  3. Nabeel Abdullah, MDPort Arthur, TX1952306565
  4. William Abide, M.D.San Marcos, TX1932307261
  5. Wael Abo-Auda, M.D.McKinney, TX1891782512
  6. Dia Abochamh, MDPort Arthur, TX1417952029
  7. Mehran Abolbashari, M.D.El Paso, TX1144633272
  8. Ossama Abou HassanTemple, TX1083252332
  9. David Abrams, MDAustin, TX1326049230
  10. Gerard Abreo, MDWebster, TX1225072507

Common questions

What is Jacob Chemmalakuzhy, M.D.'s NPI number?

Jacob Chemmalakuzhy, M.D.'s National Provider Identifier (NPI) is 1992723241, issued on Jul 17, 2006. An NPI identifies a provider in billing; it is not a license.

Where is Jacob Chemmalakuzhy, M.D. located?

The NPPES record lists a practice address at 6750 N Macarthur Blvd, Irving, TX, 75039. Phone: (972) 428-3298. Providers update this record themselves, so call before visiting.

How can I verify Jacob Chemmalakuzhy, M.D.'s license?

NPPES lists Texas license number M3986, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Jacob Chemmalakuzhy, M.D. prescribe under Medicare Part D?

In 2024, Jacob Chemmalakuzhy, M.D. had 1,776 Medicare Part D claims for 282 beneficiaries; the average among cardiovascular disease physician prescribers was 3,078. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.